InflaRx (IFRX) said late Friday it received a deficiency notice from Nasdaq for failing to meet the minimum bid requirement of $1 per share for 30 consecutive trading days.
The company has until Jan. 7, 2026, to regain compliance.
The notice has no immediate effect on the listing or trading of InflaRx's shares, the company said, adding it plans to monitor the stock price and consider options to restore compliance.